iRhom2 in the pathogenesis of oral squamous cell carcinoma.
iRhom2 in the pathogenesis of oral squamous cell carcinoma.
Mol Biol Rep. 2020 Mar 31;:
Authors: Agwae ME, Shaw RJ, Triantafyllou A, Greaney FST, Ben Salah K, Risk JM
Abstract
iRhom2 is an inactive rhomboid protease involved in diverse signalling events. It has been implicated in the pathogenesis of a number of cancer types, including oesophageal and ovarian cancer, while its closely associated family member, iRhom1, is implicated in head and neck cancer. However, a role for iRhom2 in head and neck cancer has not been investigated. Immunoblotting for iRhom2 in 54 oral squamous cell carcinoma (OSCC) and 24 paired normal tissues demonstrated higher levels of iRhom2 protein in tumour compared with normal samples (Pā<ā0.05). iRhom2 over-expression correlated with poor patient survival (Pā<ā0.0005) but with no other clinicopathological variable. Increased cell migration was observed in stably over-expressing iRhom2 clones of OSCC cell lines in the absence of increased cell proliferation, but not in the normal oral keratinocyte cell line, NOK-hTERT, and this was abrogated by knock-down of iRhom2. iRhom2 protein expression is increased in a proportion of OSCC and this up-regulation is associated with faster cell migration and decreased patient survival. These data implicate iRhom2-controlled signalling events in the pathogenesis of this cancer.
PMID: 32236893 [PubMed - as supplied by publisher]
Source: Molecular Biology Reports - Category: Molecular Biology Authors: Agwae ME, Shaw RJ, Triantafyllou A, Greaney FST, Ben Salah K, Risk JM Tags: Mol Biol Rep Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Carcinoma | Esophagus Cancer | Head and Neck Cancer | Molecular Biology | Oral Cancer | Ovarian Cancer | Ovaries | Skin Cancer | Squamous Cell Carcinoma